Adrian Espejel-Guzman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Adrian Espejel-Guzman has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Nilda Espinola-Zavaleta
Department of Nuclear Cardiology, National Institute of Cardiology Ignacio Chavez, Mexico City, Mexico
3 shared publications - Aldo Cabello-Ganem
Department of Nuclear Cardiology, National Institute of Cardiology Ignacio Chavez, Mexico City, Mexico
2 shared publications - Javier Serrano-Roman
Department of Nuclear Cardiology (V.F.-B., J.S.-R., A.C.-G., A.E.-G., E.S.-P., E.A.-R., N.E.-Z.), National Institute of Cardiology Ignacio Chavez, Mexico City
2 shared publications - Neftali Eduardo Antonio-Villa
Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez , Mexico City
2 shared publications Alberto Aranda-Fraustro
Department of Pathology (A.A.-F.), National Institute of Cardiology Ignacio Chavez, Mexico City
1 shared publication- Alexis Daniel Aparicio-Ortiz
Department of Nuclear Cardiology, National Institute of Cardiology Ignacio Chavez, Mexico City, Mexico
1 shared publication
Latest Publications
- 6 May 2026
- Published by Wiley in Echocardiography
- Vol. 43 (5) , e70481
Clinical Utility of Mechanical Echocardiographic Dispersion to Assess Left Ventricular Function and Ischemia or Infarction Detected by Gated 99M‐Tc Sestamibi‐SPECT
Background: Coronary artery disease (CAD) remains the leading cause of morbidity and mortality worldwide. Echocardiographic assessment of left ventricular (LV) asynchrony may provide additional value for detecting ischemia or infarction. Objectives: To assess the systolic and diastolic mechanical dispersion (MD) by 3D‐echocardiography and its correlation with left ventricular ejection fraction (LVEF) and ischemia or infarction by myocardial perfusion study (MPS) gated 99m‐Tc Sestamibi‐SPECT. Methods: Cross‐sectional study of patients with angina. Systolic and diastolic MD were defined as the standard deviation (SD) of the time to reach minimum ventricular volume, corrected for the R–R interval. Association with LVEF was assessed with correlation and linear regression. ROC curves identified ischemia or infarction and compared with E/A ratio, TRIVI, and E/e’ ratio. Results: 205 patients were studied with median age 62 (IQR: 54–69) years. 51% ( n = 104) presented ischemia or infarction. We observed a negative correlation with systolic ( r = −0.343, 95% −0.459 to −0.215; p < 0.001) and diastolic ( r = −0.184, 95% −0.314 to ‐0.047; p < 0.01) MD and MPS‐LVEF, which contributes to 8.9% and 11.8% of variance, respectively. Both parameters displayed an area under the curve (AUC) of 0.634 (95% 0.559–0.709, p < 0.001) and 0.604 (95% CI 0.527–0.679, p < 0.001) are shown to detect ischemia/infarction. In patients with transmural infarction the AUC for systolic MD improved to 0.691 (95% 0.582–0.801, p < 0.05). Conclusions: Systolic and diastolic MD are useful and simple parameters for assessment of LV function and ischemia or infarction.
- 6 May 2026
- Published by Wiley in Echocardiography
- Vol. 43 (5) , e70481
Clinical Utility of Mechanical Echocardiographic Dispersion to Assess Left Ventricular Function and Ischemia or Infarction Detected by Gated 99M‐Tc Sestamibi‐SPECT
Background: Coronary artery disease (CAD) remains the leading cause of morbidity and mortality worldwide. Echocardiographic assessment of left ventricular (LV) asynchrony may provide additional value for detecting ischemia or infarction. Objectives: To assess the systolic and diastolic mechanical dispersion (MD) by 3D‐echocardiography and its correlation with left ventricular ejection fraction (LVEF) and ischemia or infarction by myocardial perfusion study (MPS) gated 99m‐Tc Sestamibi‐SPECT. Methods: Cross‐sectional study of patients with angina. Systolic and diastolic MD were defined as the standard deviation (SD) of the time to reach minimum ventricular volume, corrected for the R–R interval. Association with LVEF was assessed with correlation and linear regression. ROC curves identified ischemia or infarction and compared with E/A ratio, TRIVI, and E/e’ ratio. Results: 205 patients were studied with median age 62 (IQR: 54–69) years. 51% ( n = 104) presented ischemia or infarction. We observed a negative correlation with systolic ( r = −0.343, 95% −0.459 to −0.215; p < 0.001) and diastolic ( r = −0.184, 95% −0.314 to ‐0.047; p < 0.01) MD and MPS‐LVEF, which contributes to 8.9% and 11.8% of variance, respectively. Both parameters displayed an area under the curve (AUC) of 0.634 (95% 0.559–0.709, p < 0.001) and 0.604 (95% CI 0.527–0.679, p < 0.001) are shown to detect ischemia/infarction. In patients with transmural infarction the AUC for systolic MD improved to 0.691 (95% 0.582–0.801, p < 0.05). Conclusions: Systolic and diastolic MD are useful and simple parameters for assessment of LV function and ischemia or infarction.
- Open Access
- 4 March 2024
- Vol. 62 (2) , 1-6
[Hypereosinophilic syndrome, case report and diagnostic approach].
Hypereosinophilic syndrome (HES) is a rare hematological disorder, characterized by blood and tissue eosinophilia, causing tissue damage and dysfunction. The onset of the disease is generally asymptomatic, being discovered incidentally. The objective of this article is to illustrate the rare clinical presentation in patients with chronic kidney disease. A 69-year-old male patient, with a history of type 2 diabetes and high blood pressure, was admitted to the internal medicine service with wasting syndrome under study, multiple urticarial skin lesions and peripheral blood cytopenias. During the approach to him, eosinophilia of more than 5.0 × 109 / L was evidenced, a bone marrow aspirate was performed, which revealed eosinophilic infiltration with dysplasia, biopsy of dermal lesions with mixed cellular infiltrate with a predominance of eosinophils; With the above, the diagnosis of idiopathic HES is made, after the exclusion of other evident eosinophilia etiologies. Systemic steroid treatment was started. Eosinophilic disorders represent a heterogeneous group of rare conditions, with multiple clinical manifestations, predominantly dermatological. An important association with the development of chronic kidney disease is reported, so a comprehensive approach must be carried out, with the aim of achieving an etiological diagnosis that allows early treatment and improves survival.
- 4 March 2024
- Vol. 62 (2) , 1-6
Open Access[Hypereosinophilic syndrome, case report and diagnostic approach].
Hypereosinophilic syndrome (HES) is a rare hematological disorder, characterized by blood and tissue eosinophilia, causing tissue damage and dysfunction. The onset of the disease is generally asymptomatic, being discovered incidentally. The objective of this article is to illustrate the rare clinical presentation in patients with chronic kidney disease. A 69-year-old male patient, with a history of type 2 diabetes and high blood pressure, was admitted to the internal medicine service with wasting syndrome under study, multiple urticarial skin lesions and peripheral blood cytopenias. During the approach to him, eosinophilia of more than 5.0 × 109 / L was evidenced, a bone marrow aspirate was performed, which revealed eosinophilic infiltration with dysplasia, biopsy of dermal lesions with mixed cellular infiltrate with a predominance of eosinophils; With the above, the diagnosis of idiopathic HES is made, after the exclusion of other evident eosinophilia etiologies. Systemic steroid treatment was started. Eosinophilic disorders represent a heterogeneous group of rare conditions, with multiple clinical manifestations, predominantly dermatological. An important association with the development of chronic kidney disease is reported, so a comprehensive approach must be carried out, with the aim of achieving an etiological diagnosis that allows early treatment and improves survival.
- 1 May 2023
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 16 (5) , 398-409
Assessment of Left Ventricular Myocardial Fibrosis in Adult Patients With Ebstein Anomaly: A Retrospective Cohort Study Based on Cardiac Magnetic Resonance and Histopathological Samples
Background: The association between Ebstein anomaly and myocardial fibrosis, particularly in the left ventricle, has been controversial. We aimed to assess the prevalence of replacement fibrosis with a focus on the left ventricle (LV) using cardiac magnetic resonance (CMR), make a histopathological association between LV fibrosis and CMR findings, and explore whether LV fibrosis is an independent risk factor for cardiovascular disease mortality using a derived risk score. Methods: We performed a 12-year (2009–2021) retrospective cohort of adult patients with Ebstein anomaly who underwent CMR. The CMR evaluation included a comprehensive assessment of myocardial fibrosis by late gadolinium enhancement (LGE). Four postmortem samples were obtained from our cohort and stained using Masson trichrome to characterize LV fibrosis. We used Cox-regression analysis to identify and derive a prediction score that associated LV fibrosis with cardiovascular disease mortality. Results: We included 57 adults with Ebstein anomaly (52% men; median age, 29.52 [interquartile range, 21.24–39.17] years), of whom 12 died during follow-up. LGE prevalence by CMR was observed in 52.6% in any chamber; LV-LGE in 29.8%. Histopathological findings revealed a mid-wall pattern with predominantly interstitial fibrosis and minimal replacement fibrosis. LV-LGE was associated with increased risk of cardiovascular disease mortality (hazard ratio, 6.02 [95% CI, 1.22–19.91]) attributable to lateral and mid-wall LV segment involvement. Our mortality score achieved an overall good prediction capacity (R 2 , 0.435; C statistic, 0.93; D xy , 0.86). Conclusions: There is a high prevalence of LV fibrosis replacement in adults with Ebstein anomaly, characterized by specific CMR and histological patterns. Furthermore, LV-LGE fibrosis is an independent predictor of cardiovascular disease mortality, which could be integrated into risk assessment in clinical management.
- 1 May 2023
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 16 (5) , 398-409
Assessment of Left Ventricular Myocardial Fibrosis in Adult Patients With Ebstein Anomaly: A Retrospective Cohort Study Based on Cardiac Magnetic Resonance and Histopathological Samples
Background: The association between Ebstein anomaly and myocardial fibrosis, particularly in the left ventricle, has been controversial. We aimed to assess the prevalence of replacement fibrosis with a focus on the left ventricle (LV) using cardiac magnetic resonance (CMR), make a histopathological association between LV fibrosis and CMR findings, and explore whether LV fibrosis is an independent risk factor for cardiovascular disease mortality using a derived risk score. Methods: We performed a 12-year (2009–2021) retrospective cohort of adult patients with Ebstein anomaly who underwent CMR. The CMR evaluation included a comprehensive assessment of myocardial fibrosis by late gadolinium enhancement (LGE). Four postmortem samples were obtained from our cohort and stained using Masson trichrome to characterize LV fibrosis. We used Cox-regression analysis to identify and derive a prediction score that associated LV fibrosis with cardiovascular disease mortality. Results: We included 57 adults with Ebstein anomaly (52% men; median age, 29.52 [interquartile range, 21.24–39.17] years), of whom 12 died during follow-up. LGE prevalence by CMR was observed in 52.6% in any chamber; LV-LGE in 29.8%. Histopathological findings revealed a mid-wall pattern with predominantly interstitial fibrosis and minimal replacement fibrosis. LV-LGE was associated with increased risk of cardiovascular disease mortality (hazard ratio, 6.02 [95% CI, 1.22–19.91]) attributable to lateral and mid-wall LV segment involvement. Our mortality score achieved an overall good prediction capacity (R 2 , 0.435; C statistic, 0.93; D xy , 0.86). Conclusions: There is a high prevalence of LV fibrosis replacement in adults with Ebstein anomaly, characterized by specific CMR and histological patterns. Furthermore, LV-LGE fibrosis is an independent predictor of cardiovascular disease mortality, which could be integrated into risk assessment in clinical management.
- Open Access
- 24 April 2023
- Published by Springer Nature in Clinical Rheumatology
- Vol. 42 (8) , 2247-2248
Pulmonary hypertension secondary to Takayasu arteritis and atrial septal defect
- 24 April 2023
- Published by Springer Nature in Clinical Rheumatology
- Vol. 42 (8) , 2247-2248
Open AccessPulmonary hypertension secondary to Takayasu arteritis and atrial septal defect